GenomOncology announced it will integrate Pacific Biosciences’ HiFi whole-genome sequencing secondary analysis pipeline into its Pathology Workbench reporting platform. The combined workflow is designed to translate research-use-only long-read WGS outputs into clinician-ready reports with quality control, variant interpretation, evidence curation, and report generation. GenomOncology said the integration aims to help labs standardize upstream sequencing processes while tailoring downstream reporting for specific tumor types, myeloid-focused panels, and potential clinical or reimbursement requirements. The update matters for biotech and provider diagnostics because long-read WGS adoption is often limited by the operational gap between sequencing pipelines and interpretive reporting infrastructure—especially for heterogeneous tumor samples and complex variant evidence frameworks.